Published in Radiat Res on July 01, 1990
Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell (1993) 15.70
A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell (1985) 8.30
Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell (1993) 6.40
Mechanism of action of the lexA gene product. Proc Natl Acad Sci U S A (1981) 6.13
DNA specificity of the bicoid activator protein is determined by homeodomain recognition helix residue 9. Cell (1989) 5.89
Modelling cellular behaviour. Nature (2001) 5.85
Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins. Cell (1994) 4.95
Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol (1995) 4.63
A bacterial repressor protein or a yeast transcriptional terminator can block upstream activation of a yeast gene. Nature (1985) 4.08
APC binds to the novel protein EB1. Cancer Res (1995) 3.98
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol (1995) 3.59
DNA-bound Fos proteins activate transcription in yeast. Cell (1988) 3.22
Interaction mating reveals binary and ternary connections between Drosophila cell cycle regulators. Proc Natl Acad Sci U S A (1994) 3.18
The lexA gene product represses its own promoter. Proc Natl Acad Sci U S A (1980) 3.03
Fused protein domains inhibit DNA binding by LexA. Mol Cell Biol (1992) 3.01
Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein. Proc Natl Acad Sci U S A (1994) 2.86
Yeast Cbk1 and Mob2 activate daughter-specific genetic programs to induce asymmetric cell fates. Cell (2001) 2.76
Protein interaction methods--toward an endgame. Science (1999) 2.48
Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature (1996) 2.34
LexA protein is a repressor of the colicin E1 gene. J Biol Chem (1983) 2.24
Oncogenic transformation by vrel requires an amino-terminal activation domain. Mol Cell Biol (1990) 2.15
A genetic model for interaction of the homeodomain recognition helix with DNA. Science (1991) 2.09
Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci U S A (1980) 2.08
Lung cancer induced in hamsters by low doses of alpha radiation from polonium-210. Science (1975) 1.71
Regulation of damage-inducible genes in Escherichia coli. J Mol Biol (1982) 1.63
Timing of the steps in transformation of C3H 10T 1/2 cells by X-irradiation. Nature (1984) 1.54
Repression of transcription in yeast. Cell (1985) 1.53
Gene activation and DNA binding by Drosophila Ubx and abd-A proteins. Cell (1989) 1.53
Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci U S A (1995) 1.37
Norfloxacin dihydrate. Acta Crystallogr C (2000) 1.33
Protease inhibitors suppress radiation-induced malignant transformation in vitro. Nature (1979) 1.33
Human RNA polymerase II subunit hsRPB7 functions in yeast and influences stress survival and cell morphology. Mol Biol Cell (1995) 1.32
Isolation of Drosophila cyclin D, a protein expressed in the morphogenetic furrow before entry into S phase. Proc Natl Acad Sci U S A (1996) 1.30
Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? Oncogene (2000) 1.26
Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J (1997) 1.25
Hypothalamic actions of neuromedin U. Endocrinology (2002) 1.21
Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin Cancer Res (2000) 1.19
roughex down-regulates G2 cyclins in G1. Genes Dev (1997) 1.19
"Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections. Proc Natl Acad Sci U S A (1999) 1.18
Specific DNA recognition and intersite spacing are critical for action of the bicoid morphogen. Mol Cell Biol (1994) 1.17
DNA binding is not sufficient for nuclear localization of regulatory proteins in Saccharomyces cerevisiae. Mol Cell Biol (1986) 1.15
An artificial cell-cycle inhibitor isolated from a combinatorial library. Proc Natl Acad Sci U S A (1998) 1.15
Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis. Br J Dermatol (1986) 1.15
p16 proteins from melanoma-prone families are deficient in binding to Cdk4. Oncogene (1995) 1.14
Enhancement of X-ray transformation by 12-O-tetradecanoyl-phorbol-13-acetate in a cloned line of C3H mouse embryo cells. Cancer Res (1978) 1.12
A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences. New Biol (1991) 1.12
Acute hematological effects of solar particle event proton radiation in the porcine model. Radiat Res (2013) 1.10
The actions of tuberoinfundibular peptide on the hypothalamo-pituitary axes. Endocrinology (2001) 1.08
Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology (2001) 1.05
Effects of proton radiation dose, dose rate and dose fractionation on hematopoietic cells in mice. Radiat Res (2010) 1.05
Applications of interaction traps/two-hybrid systems to biotechnology research. Curr Opin Biotechnol (1994) 1.05
Effect of time and duration of exposure to 12-O-tetradecanoylphorbol-13-acetate on x-ray transformation of C3H 10T 1/2 cells. Cancer Res (1980) 1.04
Demonstration of intra- and extracellular localization of bullous pemphigoid antigen using cryofixation and freeze substitution for postembedding immunoelectron microscopy. Arch Dermatol Res (1989) 1.02
The impact of two-hybrid and related methods on biotechnology. Trends Biotechnol (1998) 1.02
Kinetics of neutrophils in mice exposed to radiation and/or granulocyte colony-stimulating factor treatment. Radiat Res (2013) 1.01
Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene (1999) 1.00
Cells that register logical relationships among proteins. Proc Natl Acad Sci U S A (1997) 0.99
Regulation and autoregulation by lexA protein. Biochimie (1983) 0.98
GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa. Lancet (1986) 0.96
Protease activity in a hapten-induced model of ulcerative colitis in rats. Dig Dis Sci (1997) 0.96
Dimerization of the human papillomavirus E7 oncoprotein in vivo. Virology (1995) 0.96
Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol Biomarkers Prev (2000) 0.96
LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A (1998) 0.95
1,4-pentadienyl-3-sulfonamides: frameworks for "disfavored" radical cascade cyclizations. Org Lett (2001) 0.93
Assessing borderline personality disorder with self-report, clinical interview, or semistructured interview. Am J Psychiatry (1984) 0.92
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate (2001) 0.92
Effect of SPE-like proton or photon radiation on the kinetics of mouse peripheral blood cells and radiation biological effectiveness determinations. Astrobiology (2013) 0.92
Interactions between polonium-210 alpha-radiation, benzo(a)pyrene, and 0.9% NaCl solution instillations in the induction of experimental lung cancer. Cancer Res (1978) 0.92
Rapid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody. Br J Dermatol (1987) 0.92
Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro. Proc Natl Acad Sci U S A (1985) 0.91
The ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-1. J Biol Chem (1999) 0.91
Selection of genetic agents from random peptide aptamer expression libraries. Methods Enzymol (2000) 0.91
Effects of solar particle event proton radiation on parameters related to ferret emesis. Radiat Res (2013) 0.91
Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology (2001) 0.91
Effects of protease inhibitors on nuclear binding of glucocorticoid hormones in C3H10T1/2 cells. FEBS Lett (1985) 0.91
Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch Biochem Biophys (1997) 0.90
Targeted localized degradation of Paired protein in Drosophila development. Curr Biol (2000) 0.89
Inhibition of oral carcinogenesis by a protease inhibitor. J Natl Cancer Inst (1986) 0.89
Effect of dose rate on the induction of experimental lung cancer in hamsters by alpha radiation. Radiat Res (1985) 0.88
Morphometric and histological analysis of the lungs of Syrian golden hamsters. J Anat (1978) 0.88
Antipain, but not cycloheximide, suppresses radiation transformation when present for only one day at five days post-irradiation. Carcinogenesis (1982) 0.88
Targeted modification and transportation of cellular proteins. Proc Natl Acad Sci U S A (2000) 0.86
DNA repair and malignant transformation: effect of X irradiation, 12-O-tetradecanoyl-phorbol-13-acetate, and protease inhibitors on transformation and sister-chromatid exchanges in mouse 10T 1/2 cells. Radiat Res (1979) 0.86
Large-scale preparation of plasmid DNA. Curr Protoc Mol Biol (2001) 0.86
A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors. Proc Natl Acad Sci U S A (1987) 0.85
The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis. Mult Scler (2006) 0.85
Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res (1983) 0.85
Evidence that a second event in X-ray-induced oncogenic transformation in vitro occurs during cellular proliferation. Radiat Res (1984) 0.85
Effects of protease inhibitors on radiation transformation in vitro. Cancer Res (1981) 0.84
Serial sacrifice study of pathogenesis of 210Po-induced lung tumors in Syrian golden hamsters. Cancer Res (1978) 0.84
Central orexin A has site-specific effects on luteinizing hormone release in female rats. Endocrinology (2003) 0.84
Levels of proteolytic activities as intermediate marker endpoints in oral carcinogenesis. Cancer Epidemiol Biomarkers Prev (1995) 0.84
Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor. Cancer Epidemiol Biomarkers Prev (1999) 0.84
Histochemical, light and electron microscopic study of polonium-210 induced peripheral tumors in hamster lungs: evidence implicating the Clara cell as the cell of origin. Eur J Cancer (1977) 0.83
Antioxidant dietary supplementation in mice exposed to proton radiation attenuates expression of programmed cell death-associated genes. Radiat Res (2011) 0.83
Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Carcinogenesis (1989) 0.82
Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell (1994) 0.82
Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis (1985) 0.82